wellrank.ai
Fridays logo

Fridays

First cited by AI Jun 12, 2026
joinfridays.com

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Fridays, through Jun 13, 2026.

8.3%

Avg position when mentioned: 3.0

By engine

Where Fridays is strong, and where it is invisible.

  • Perplexity
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 1 positive mentions
  • 2 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Fridays

PerplexityJun 13, 2026, 11:14 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

The providers in your results that explicitly say they use licensed U.S. pharmacies are OrderlyMeds and Empower Pharmacy.[1][2] OrderlyMeds says it “exclusively works with pharmacies based in the United States,” and that medication is compounded at “U.S. based licensed pharmacies.”[1] Empower Pharmacy says it offers compounded GLP-1 injections from its 503A PCAB-accredited compounding pharmacy and that it is “licensed to ship nationwide.”[2] A few other providers in your results say they use regulated or licensed compounding pharmacies, but the wording is less specific about U.S. licensing: Fridays says its compounded GLP-1 medications are sourced from “rigorously regulated pharmacies,” but the result does not name the pharmacies or explicitly say “licensed U.S. pharmacies” on that page.[8] Henry Meds is described in the search results as using 503A or 503B compounding pharmacies, including named partners such as Belmar, Strive, Epiq Scripts, and Casa Pharma Rx, but the result does not clearly state in the excerpt that all are licensed U.S. pharmacies.[6] If you want, I can turn this into a short buyer’s comparison of these providers based on pharmacy licensing, transparency, and GLP-1 availability.

Mentioned in position 3 of 8

Read full answer with sources →
PerplexityJun 12, 2026, 10:28 UTC
My compounded semaglutide provider shut down. Where should I move my treatment?

If your compounded semaglutide provider shut down, the safest move is to transfer your care to a licensed clinician and a reputable 503A compounding pharmacy or a telehealth weight-loss clinic that uses one. If you need an immediate replacement, commonly cited options include Henry Meds, Shed, Fridays, Alloy, and Brello; each offers clinician review and home shipping, but availability, pricing, and eligibility vary by state and plan.[2][3][5] A practical way to choose: Henry Meds: a broader telehealth weight-loss program with compounded semaglutide and published monthly pricing tiers.[2] Shed: another established online option with compounded semaglutide and dose-based pricing.[2] Fridays: includes coaching and lab support, and fills through partner compounding pharmacies.[2] Alloy: best if you want ongoing doctor messaging and dose adjustments; it is targeted more toward menopause-related care and is not available in several states.[3] Brello: offers provider review plus direct shipping, but you should compare total cost carefully before switching.[5] Before moving, verify these points with any new provider: The medication is prescribed by a licensed clinician after a real medical review.[2][3][5] The pharmacy is properly licensed and ideally 503A-compounding compliant.[1] Your state is covered, since several services exclude certain states.[1][3] They can continue your current dose and formulation safely, since compounded semaglutide products are not standardized across pharmacies.[2][3] If you want the lowest-friction switch, ask the new clinic these three questions: “Can you transfer me at my current dose?” “Which pharmacy will fill it?” “What is the monthly total including medication, visits, and shipping?” If you tell me your state and whether you want lowest cost, fastest restart, or most physician support, I can narrow this to the best fit.

Mentioned in position 3 of 5

Read full answer with sources →
PerplexityJun 12, 2026, 10:26 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Based on the provided search results, the following compounded GLP-1 providers explicitly state that they use licensed US pharmacies (specifically citing 503A or 503B facilities based in the United States): OrderlyMeds Explicitly states they work "exclusively with pharmacies based in the United States." Lists specific US partners: SmartPharmaRx, Casa, and PerfectRx/PerfectionRx. Describes itself as a "100% online platform that connects patients to licensed healthcare professionals in all 50 states." Empower Pharmacy States their medications are made at a "503A PCAB-Accredited compounding pharmacy" (a US standard). Confirms they are licensed to "ship nationwide, including Puerto Rico," indicating a US-based operation. Henry Meds (and its partner Adonis Health Inc.) Described as "upfront" about using both 503A and 503B compounding pharmacies. Cites partner pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx (all US-based entities). Fridays Weight Loss Program (joinfridays.com) States they "deliver from 503A and 503B certified compounding pharmacies." While they do not name all partners on marketing pages, they reference Beaker Pharmacy as a fulfillment partner. The FDA clarification mentioned in the text notes that compounded semaglutide must legally come from 503A pharmacies (US standard), which Fridays claims to use. Schaffner Pharmacy Explicitly states their products are made by "FDA certified 503B compounding pharmacies," which are US-regulated facilities. Important Regulatory Context (from results): FDA Shortage Status: As of May 2025, the FDA shortages for semaglutide and tirzepatide injections have been resolved. Consequently, pharmacies are generally no longer allowed to regularly compound "essentially copies" of commercially available GLP-1s. Current Availability: Compounded versions are now largely phased out and should only be used for specific medical needs that commercial products cannot meet (e.g., non-standard doses or removing allergens). 503A vs. 503B: 503A pharmacies are traditional compounding pharmacies licensed by state boards for individual patients, while 503B facilities are outsourcing facilities regulated by the FDA. Both are US-licensed entities. Summary: The providers most clearly identified as using licensed US pharmacies are OrderlyMeds, Empower Pharmacy, Henry Meds, Fridays, and Schaffner Pharmacy. OrderlyMeds is the most explicit about its exclusive use of US-based partners.

Mentioned in position 12 of 14

Read full answer with sources →

Public AI visibility history

Daily rank of Fridays on our buyer intent questions, per category. A dash means the engines did not cite Fridays at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Compounded GLP-1s#39#36

TL;DR

Fridays (joinfridays.com) is a telehealth platform focused on compounded medications, including compounded GLP-1 therapies such as semaglutide. The company operates a direct-to-consumer model connecting patients with licensed providers and compounding pharmacies. According to WellRank's latest index, Fridays ranks 14th in AI answer visibility for compounded GLP-1s, capturing 8% share of AI-generated answers in that category, with its mentions skewing positive or neutral across the three citations tracked in the WellRank corpus.

Company Overview

Fridays is a telehealth company that facilitates access to compounded medications, with a notable focus on GLP-1 receptor agonists used for weight management. Its business model connects patients with clinicians online and routes prescriptions to compounding pharmacies, handling the end-to-end care and fulfillment experience. Founding details and headquarters are not publicly disclosed.

Product Features

  • Compounded semaglutide and other compounded GLP-1 medications
  • Online telehealth consultations with licensed providers
  • Prescription fulfillment through compounding pharmacy partners
  • Ongoing patient support and medication management
  • Direct-to-consumer subscription or treatment plan structure

Target Market

Fridays primarily serves adults in the United States seeking access to compounded GLP-1 therapies for weight loss or metabolic health. It appears to target patients who face cost or access barriers with brand-name GLP-1 drugs. Geographic reach is U.S.-focused, consistent with the compounded telehealth sector.

Buyer Personas

  • A cost-conscious adult seeking a more affordable alternative to branded semaglutide who prefers managing care entirely online.
  • A patient who has struggled to obtain a GLP-1 prescription through traditional primary care and is looking for a streamlined telehealth pathway.
  • A health-motivated individual already familiar with GLP-1 therapies who wants a convenient refill and monitoring service without frequent in-person visits.
  • A consumer who has researched compounded GLP-1 options through comparison sites and arrived at Fridays via an AI-generated recommendation or listicle.

Funding & Performance

Funding stage, investor details, and company valuation are not publicly disclosed.

Recent Developments

Fridays has been surfacing organically in AI-generated answers about compounded GLP-1s, a category that has seen significant regulatory and market attention as the FDA has weighed the future of compounded semaglutide. The company's compounded medication offering is detailed at joinfridays.com/compounded-medications. Industry context around the regulatory trajectory of compounded GLP-1s is covered by sources such as GoodRx's overview of compounded GLP-1 availability, which reflects the broader environment Fridays operates in.

Competitive Landscape

Based on WellRank co-mention data, Fridays appears most frequently alongside Henry Meds, OrderlyMeds, Epiq Scripts, Empower Pharmacy, Casa Pharma Rx, and Strive Pharmacy in AI-generated answers about compounded GLP-1s. This peer set represents a mix of telehealth prescribing platforms and compounding pharmacy direct marketers. A broader view of the compounded semaglutide provider landscape is reflected in resources like this compounding pharmacy comparison and Empower Pharmacy's GLP-1 information page, both of which AI engines have cited in answers mentioning Fridays.

Fridays vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Fridays logo
FridaysThis brand
#36
8.3%
Henry Meds logo
Henry Meds

3 shared answers

#4
33.3%
Casa Pharma Rx logo
Casa Pharma Rx

2 shared answers

#35
8.3%
Empower Pharmacy logo
Empower Pharmacy

2 shared answers

#2
41.7%
Epiq Scripts logo
Epiq Scripts

2 shared answers

#34
8.3%

Email me when overtakes Fridays

One email the day the ranks flip. Nothing else.

User Sentiment

Among the three AI-engine mentions tracked by WellRank, one is positive and two are neutral, with no cautious or mixed tones recorded. This suggests Fridays is referenced matter-of-factly as a legitimate option in compounded GLP-1 comparisons rather than attracting critical commentary. Broader public sentiment is not yet well documented in major review platforms, consistent with the brand's emerging profile.

Pricing

Pricing is not published in a stable, widely available format. As is common in the compounded telehealth sector, costs likely vary based on medication dosage, consultation fees, and subscription structure. Prospective patients are directed to the platform itself for current pricing details.

Sources cited around Fridays

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Fridays weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Fridays? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.